dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.date.accessioned2014-05-27T11:21:56Z
dc.date.available2014-05-27T11:21:56Z
dc.date.created2014-05-27T11:21:56Z
dc.date.issued2006-08-01
dc.identifierAmerican Journal of Clinical Pathology, v. 126, n. 2, p. 284-293, 2006.
dc.identifier0002-9173
dc.identifierhttp://hdl.handle.net/11449/69020
dc.identifier10.1309/UU2JADUEHDWATVM9
dc.identifierWOS:000239216000017
dc.identifier2-s2.0-33746683763
dc.identifier5240998569868081
dc.description.abstractLaryngeal carcinomas are aggressive neoplasms with controversial association with the human papillomavirus (HPV) and Epstein-Barr virus (EBV). So far, the impairment of p53 protein function and its impact on cellular proliferation has not been studied adequately in these tumors. In this work, molecular biologic techniques were used to assess the frequency of HPV and EBV in 110 squamous cell carcinomas of the larynx. In addition, accumulation of p53 and Ki-67 cell proliferation antigen expression in malignant cells was assessed by immunohistochemical analysis. High-grade HPV was found in 37.3% of cases, and none had demonstrable EBV infection. Accumulation of p53 was found in 78.2% of the cases, and it was related to a high Ki-67 labeling index and higher histologic grade. The results demonstrate association of HPV with more than one third of laryngeal carcinomas studied, mainly glottic tumors. Tumors with increased cell proliferation were more frequently high grade, with p53 accumulation and lymph node metastasis. © American Society for Clinical Pathology.
dc.languageeng
dc.relationAmerican Journal of Clinical Pathology
dc.relation2.413
dc.relation1,002
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectEBV
dc.subjectEpstein-Barr virus
dc.subjectHPV
dc.subjectHuman papillomavirus
dc.subjectLaryngeal cancer
dc.subjectp53
dc.subjectTumor growth fraction
dc.subjectKi 67 antigen
dc.subjectprotein p53
dc.subjectadult
dc.subjectaged
dc.subjectantigen expression
dc.subjectcancer cell
dc.subjectcancer grading
dc.subjectcell proliferation
dc.subjectcontrolled study
dc.subjectdisease severity
dc.subjectEpstein Barr virus
dc.subjectfemale
dc.subjecthistology
dc.subjecthuman
dc.subjectimmunohistochemistry
dc.subjectlabeling index
dc.subjectlarynx carcinoma
dc.subjectlarynx tumor
dc.subjectlymph node metastasis
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmolecular biology
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectprotein function
dc.subjectsquamous cell carcinoma
dc.subjecttumor growth
dc.subjecttumor suppressor gene
dc.subjectvirus infection
dc.subjectWart virus
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectCarcinoma, Squamous Cell
dc.subjectCell Proliferation
dc.subjectDNA, Neoplasm
dc.subjectDNA, Viral
dc.subjectEpstein-Barr Virus Infections
dc.subjectFemale
dc.subjectFluorescent Antibody Technique, Indirect
dc.subjectHerpesvirus 4, Human
dc.subjectHumans
dc.subjectImmunoenzyme Techniques
dc.subjectKi-67 Antigen
dc.subjectLaryngeal Neoplasms
dc.subjectLarynx
dc.subjectLymph Nodes
dc.subjectLymphatic Metastasis
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPapillomaviridae
dc.subjectPapillomavirus Infections
dc.subjectRetrospective Studies
dc.subjectTumor Suppressor Protein p53
dc.titleHuman papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución